CClinicalTrials.gg
Not yet recruitingNCT06450938Updated Jun 25, 2024

No Code Artificial Intelligence to Detect Radiographic Features Associated With Unsatisfactory Endodontic Treatment

An interventional study of AI guidance for finding radiographic features in Endodontically Treated Teeth, Endodontic Underfill and Endodontic Overfill, sponsored by University of Copenhagen. Not yet recruiting. Open to participants aged 20 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-06-25.

Sponsored by University of Copenhagen · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Primary completion was expected by Nov 2024, 1 year 10 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
20 Years to 40 Years
Sex
All
01

Study summary

Developing neural network-based models for image analysis can be time-consuming, requiring dataset design and model training. No-code AI platforms allow users to annotate object features without coding. Corrective annotation, a "human-in-the-loop" approach, refines AI segmentations iteratively. Dentistry has seen success with no-code AI for segmenting dental restorations. This study aims to assess radiographic features related to root canal treatment quality using a "human-in-the-loop" approach.

Read the detailed description

The emergence of artificial intelligence (AI) and specifically deep learning (DL) have shown great potential in finding radiographic features and treatment planning in the field of cariology and endodontics. A growing body of literature suggests that DL models might assist dental practitioners in detecting radiographic features such as carious lesions, and periapical lesions, as well as predicting the risk of pulp exposure when doing caries excavation therapy. Although, the current literature lacks sufficient research on the interaction of participants and AI in an AI-based platform for detecting features associated with technical quality of endodontic treatment. This prospective randomized controlled trial aims to assess the performance of students when using an AI-based platform for detecting features associated with technical quality of endodontic treatment and predicting the long term prognosis of the treatment. The hypothesis is that participants' performance in the group with access to AI responses is similar to the control group without access to AI responses.

02

Conditions studied

  • Endodontically Treated Teeth
  • Endodontic Underfill
  • Endodontic Overfill
  • Apical Periodontitis

Keywords

  • Artificial Intelligence
  • Endodontic treatment
03

In context

Periodontitis

1,635 studies on the registry are indexed under Periodontitis; 327 are open to participants now.

This study's planned enrollment of 80 is above the median of 45 across 1,191 interventional studies indexed under Periodontitis.

Browse Periodontitis studies →

Lead sponsor

University of Copenhagen is the lead sponsor of 450 studies on the registry; 61 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

1.Being a last year dental student at the university of Copenhagen

Exclusion criteria

Exclusion Criteria:

  1. Having any previous AI-related experiences
  2. Not accepting to sign the informed consent
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    participants using guidance from artificial Intelligence

    the experimental arm refers to the group of participants who have access to the AI-based platform for detecting features associated with the technical quality of endodontic treatment. These participants will utilize the AI assistance during the study.

    Device: AI guidance for finding radiographic features

  • No intervention
    Control arm without any guidance from artificial Intelligence

    the control arm consists of participants who do not have access to the AI-based platform. They will perform the same tasks or assessments as those in the experimental arm but without the assistance of AI.

Interventions

  • DeviceAI guidance for finding radiographic features

    A secured website was made for the trial in which each student could log in using the assigned number. All the image datasets were uploaded to this website. The students will be randomly assigned to the experiment and control group. Both students were asked to segment the features associated with the quality of root canal treatment and predict the prognosis of treatment while the experiment group had access to AI guidance and the control group didn't.

06

What researchers measure

Primary outcomes

  1. Accuracy

    Accuracy represents how closely a result aligns with the true value or standard. Accuracy of participants at experiment and control group in correctly finding the radiographic features and predicting the outcomes is one of our primary outcomes. the reference for the comparison is the consensus of three experts in dentistry.

    Time frame: through data collection, an average of 6 months

  2. Sensitivity

    This measure quantifies the proportion of true positive results (correctly identified cases) out of all positive cases. High sensitivity indicates that one is good at detecting the condition. Sensitivity of participants at experiment and control group in correctly finding the radiographic features and predicting the outcomes is one of our primary outcomes. The comparison is made against the consensus judgment of three experts in dentistry.

    Time frame: through data collection, an average of 6 months

  3. Specificity

    Specificity measures the proportion of true negative results out of all negative cases. Specificity of participants at experiment and control group in correctly finding the radiographic features and predicting the outcomes is one of our primary outcomes. The comparison is made against the consensus judgment of three experts in dentistry.

    Time frame: through data collection, an average of 6 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 25, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06450938
Lead sponsor
University of Copenhagen
Collaborators
Queen Mary University of London
Responsible party
Lars Bjørndal (Associate Professor, University of Copenhagen) — Principal investigator
First posted
Jun 10, 2024
Start date
Jul 30, 2024 (estimated)
Primary completion
Nov 13, 2024 (estimated)
Completion
Dec 13, 2024 (estimated)
Last update
Jun 25, 2024

Study contacts

Shaqayeq Ramezanzade, Phd
Contact
shaqayeq.ramezanzade@gmail.com
55278370
Lars Bjørndal, Prof.
principal investigator · University of Copenhagen Department of Odontology Cariology and Endodontics

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion